Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

Revvity Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 14, 2023 / 12:20PM GMT
Release Date Price: R$20.99
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst from Bank of America, and welcome to our 2023 Global Healthcare Conference. Our next company up today live from London is Revvity. And with us is Max Krakowiak, CFO. Thanks, Max, for being here.

Maxwell Krakowiak
Revvity, Inc. - Senior VP & CFO

Yes. Thanks for having us.

Questions & Answers

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

We'll have a shaft for a bit, and then we'll open the Q&A up to the audience. But I guess to kick off, it's been a year since you announced plans to transform PKI into Revvity and 1 quarter since the formal split. Certainly, given some of the slowdown we've seen in some of the traditional tools markets that the business you spread out the same. That seems like a really good idea. I guess that said, I still have a lot of clients asking who is Revvity. And can you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot